Financial statements Pharmavit Polska
Balance sheet data of PHARMAVIT POLSKA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 453 089,57 | 506 002,93 | 561 970,85 | 554 596,39 | 592 136,03 | 1 264 927,01 |
| A. Fixed assets | 59 121,69 | 0,00 | 0,00 | 0,00 | 0,00 | 81 913,78 |
| B. Current assets | 393 967,88 | 506 002,93 | 561 970,85 | 554 596,39 | 592 136,03 | 1 183 013,23 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 453 089,57 | 506 002,93 | 561 970,85 | 554 596,39 | 592 136,03 | 1 264 927,01 |
| A. Equity | -105 895,89 | -56 236,06 | -159 436,32 | -103 463,03 | 888,12 | -773 320,54 |
| B. Liabilities and provisions for liabilities | 558 985,46 | 562 238,99 | 721 407,17 | 658 059,42 | 591 247,91 | 2 038 247,55 |
| I. Long-term liabilities | - | - | 173 000,00 | 49 332,53 | 21 687,54 | 1 203 021,30 |
| II. Short-term liabilities | 558 985,46 | 562 238,99 | 548 407,17 | 608 726,89 | 569 560,37 | 811 914,29 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.